Skip to site content

As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon. Updates regarding government operating status and resumption of normal operations can be found at www.opm.gov . Despite the lapse in appropriations, IHS will continue to provide direct clinical health care services as well as referrals for contracted services that cannot be provided through IHS clinics. For more information on how IHS is impacted, visit: HHS Contingency Plan

Division of Diabetes Treatment and Prevention

Diabetes Standards of Care & Clinical Practice Resources

Lipid Management

Cardiovascular disease (CVD) is a major cause of morbidity and mortality for individuals with diabetes. Appropriate use of statin therapy results in significant CVD risk reduction for adults with diabetes.

Quick Links:
Diabetes Standards of Care
(click to expand)

Standards of Care Topics

» View All Topics

Recommendations At-a-Glance
for All Topics

» Online version
» Print version [PDF – 453 KB]

Lipid Management Sections

Quickly jump to a section on this page by clicking on one of the links below.

Section 1 – Clinical Practice Recommendations: Lipid Management
Section 2 – Clinician and Educator Resources: Lipid Management
Section 3 – Patient Education Resources: Lipid Management

Clinical Practice Recommendations

Recommendations for Lipid Management

Measurement

Order a lipid panel (total cholesterol, LDL, HDL, triglycerides):
1. at diagnosis of diabetes
2. if <40 years old and not on a statin, consider annual lipid panel
3. at age 40 if not yet on a statin to establish treatment baseline
4. as needed every 1-2 years (e.g., to evaluate adherence to lipid therapy)
See Diabetes Treatment Algorithm: Lipid and Aspirin Therapy in Type 2 Diabetes.

Treatment

Implement a treatment plan to achieve lipid management goals:
- Lifestyle Therapy: Lifestyle therapy, including nutrition and physical activity, weight management, and smoking cessation, is indicated for all patients with type 2 diabetes, even those with "normal" lipid levels.
- Statin Therapy: Medication recommendations can be found in the Diabetes Treatment Algorithm: Lipid and Aspirin Therapy in Type 2 Diabetes.

Statin Treatment Recommendations

Statin Treatment Recommendations for People with Diabetes

The most effective pharmacologic lipid treatment to reduce risk for CVD events is statin therapy. For patients who cannot tolerate a particular statin, it is reasonable to try using a different statin. If no statin is tolerated, consider a non-statin medication to lower LDL cholesterol; however, there is little evidence of CVD benefit from non-statin lipid medications.

For all patients with diabetes, initiate lifestyle therapy, then:

Lifestyle therapy

¹ CVD Risk Factors include: LDL ≥100mg/dL, High Blood Pressure, Smoking, or Overweight/Obesity

² Overt CVD includes people with a history of a cardiovascular event (heart attack, stroke, stable or unstable angina, peripheral artery disease, transient ischemic attack, or coronary or other arterial revascularization).

³ Statin Therapy:

Moderate Intensity: Atorvastatin 10-20 mg, Simvastatin 20-40 mg, Pravastatin 40mg, Lovastatin 40-80 mg, Fluvastatin 80 mg, Rosuvastatin 5-10 mg
High intensity: Atorvastatin 40-80 mg, Rosuvastatin 20-40 mg

For a text description of the information in the diagram above:

Initiate lifestyle therapy for all patients with diabetes.
Patients <40 years of age:
- Without CVD risk factors¹, should not receive statin therapy.
- With CVD risk factors¹, should receive moderate or high intensity statin therapy³.
- With overt CVD², should receive high intensity statin therapy³.
Patients 40-75 years of age:
- Without CVD risk factors¹, should receive moderate intensity statin therapy³.
- With CVD risk factors¹, should receive high intensity statin therapy³.
- With overt CVD², should receive high intensity statin therapy³.
Patients >75 years of age:
- Without CVD risk factors¹, should receive moderate intensity statin therapy³.
- With CVD risk factors¹, should receive moderate or high intensity statin therapy³.
- With overt CVD², should receive high intensity statin therapy³.

¹ CVD Risk Factors include: LDL ≥100mg/dL, High Blood Pressure, Smoking, or Overweight/Obesity

³ Statin Therapy:

Moderate Intensity: Atorvastatin 10-20 mg, Simvastatin 20-40 mg, Pravastatin 40mg, Lovastatin 40-80 mg, Fluvastatin 80 mg, Rosuvastatin 5-10 mg
High intensity: Atorvastatin 40-80 mg, Rosuvastatin 20-40 mg

Notes:

Check liver function before starting statin therapy and monitor periodically as indicated.
Statins are contraindicated in pregnancy and nursing mothers. Consider pregnancy risk when prescribing statins for reproductive age women.